These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2575829)

  • 21. [Role of endothelial nitric oxide in the regulation of the vasomotor system].
    Michel JB
    Pathol Biol (Paris); 1998 Mar; 46(3):181-9. PubMed ID: 9769914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The nitric oxide-cyclic GMP signal transduction system for intracellular and intercellular communication.
    Murad F; Forstermann U; Nakane M; Pollock J; Tracey R; Matsumoto T; Buechler W
    Adv Second Messenger Phosphoprotein Res; 1993; 28():101-9. PubMed ID: 7691121
    [No Abstract]   [Full Text] [Related]  

  • 23. Sustained nitric oxide exposure decreases soluble guanylate cyclase mRNA and enzyme activity in pulmonary artery smooth muscle.
    Scott WS; Nakayama DK
    J Surg Res; 1998 Sep; 79(1):66-70. PubMed ID: 9735242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Guanylate cyclases: physiological processes mediated by cyclic GMP].
    Rivero-Vilches F; de Frutos S; Rodríguez-Puyol M; Rodríguez-Puyol D; Saura M
    Nefrologia; 2001; 21(3):233-9. PubMed ID: 11471303
    [No Abstract]   [Full Text] [Related]  

  • 25. Nitric oxide. A novel signal transduction mechanism for transcellular communication.
    Ignarro LJ
    Hypertension; 1990 Nov; 16(5):477-83. PubMed ID: 1977698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Haem-dependent activation of guanylate cyclase and cyclic GMP formation by endogenous nitric oxide: a unique transduction mechanism for transcellular signaling.
    Ignarro LJ
    Pharmacol Toxicol; 1990 Jul; 67(1):1-7. PubMed ID: 1975691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Properties and regulation of guanylate cyclase and some proposed functions for cyclic GMP.
    Murad F; Arnold WP; Mittal CK; Braughler JM
    Adv Cyclic Nucleotide Res; 1979; 11():175-204. PubMed ID: 40407
    [No Abstract]   [Full Text] [Related]  

  • 28. [Nitric oxide: from endogenous vasodilator to biologic mediator].
    Berrazueta JR; López-Jaramillo P; Moncada S
    Rev Esp Cardiol; 1990; 43(7):421-31. PubMed ID: 2093954
    [TBL] [Abstract][Full Text] [Related]  

  • 29. N-hydroxylamine is not an intermediate in the conversion of L-arginine to an activator of soluble guanylate cyclase in neuroblastoma N1E-115 cells.
    Pou S; Pou WS; Rosen GM; el-Fakahany EE
    Biochem J; 1991 Feb; 273 ( Pt 3)(Pt 3):547-52. PubMed ID: 1671745
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Formation of nitric oxide from L-arginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylate cyclase.
    Knowles RG; Palacios M; Palmer RM; Moncada S
    Proc Natl Acad Sci U S A; 1989 Jul; 86(13):5159-62. PubMed ID: 2567995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nitric oxide from L-arginine stimulates the soluble guanylate cyclase in adrenal glands.
    Palacios M; Knowles RG; Palmer RM; Moncada S
    Biochem Biophys Res Commun; 1989 Dec; 165(2):802-9. PubMed ID: 2480784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Halothane and the guanylate cyclase system.
    Nakamura K; Toda H; Hatano Y
    Anesthesiology; 1993 Mar; 78(3):617-8. PubMed ID: 8096127
    [No Abstract]   [Full Text] [Related]  

  • 33. Haem-dependent activation of cytosolic guanylate cyclase by nitric oxide: a widespread signal transduction mechanism.
    Ignarro LJ
    Biochem Soc Trans; 1992 May; 20(2):465-9. PubMed ID: 1356858
    [No Abstract]   [Full Text] [Related]  

  • 34. Contemporary Approaches to Modulating the Nitric Oxide-cGMP Pathway in Cardiovascular Disease.
    Kraehling JR; Sessa WC
    Circ Res; 2017 Mar; 120(7):1174-1182. PubMed ID: 28360348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of cytosolic guanylyl cyclase by nitric oxide: the NO-cyclic GMP signal transduction system.
    Murad F
    Adv Pharmacol; 1994; 26():19-33. PubMed ID: 7913616
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nitric oxide synthesis in endothelial cytosol: evidence for a calcium-dependent and a calcium-independent mechanism.
    Mülsch A; Bassenge E; Busse R
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Dec; 340(6 Pt 2):767-70. PubMed ID: 2576763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of cytosolic guanylyl cyclase by porphyrins and metalloporphyrins.
    Ignarro LJ
    Adv Pharmacol; 1994; 26():35-65. PubMed ID: 7913618
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nitric oxide: a guardian for vascular grafts?
    de Mel A; Murad F; Seifalian AM
    Chem Rev; 2011 Sep; 111(9):5742-67. PubMed ID: 21663322
    [No Abstract]   [Full Text] [Related]  

  • 39. Regulation of guanylate cyclase by atrial natriuretic factor and the role of cyclic GMP in vasodilation.
    Murad F; Leitman DC; Bennett BM; Molina C; Waldman SA
    Am J Med Sci; 1987 Sep; 294(3):139-43. PubMed ID: 2889359
    [No Abstract]   [Full Text] [Related]  

  • 40. Potential role of type 5 phosphodiesterase inhibition in the treatment of congestive heart failure.
    Katz SD
    Congest Heart Fail; 2003; 9(1):9-15. PubMed ID: 12556672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.